As shown in Figures 6A–C, diabetes induced the upregulation of serum TNF-α, IL-6, and IL-1β, and treatment with anti-ANGPTL3/IL22 showed prominent reversal compared with mIL22Fc or anti-ANGPTL3 alone. Here, TNF is linked to diabetes mellitus.